Our plans for a new flagship NHS Medicines Manufacturing Centre (MMC) to serve patients across the North East and North Cumbria have recently been approved.

The new regional facility, based in Seaton Delaval, will produce large volumes of chemotherapy treatment, as well as other ‘ready to administer’ injectable medicines.

On the latest episode of Providers Podcast we're joined by the MMCs Head of Production Kyle Winn and Head of Quality Laura Davies. They describe in detail what will take place in the MMC and how it will benefit patients, staff and the region as a whole.